^

News Commentary

Break the bottlenecks: Make health access real for all Filipinos

Alvin Manalansan - Philstar.com
Break the bottlenecks: Make health access real for all Filipinos
Stock image of a dextrose hanging on stainless steel IV stand.
Image by Stefan Schweihofer from Pixabay

For too many Filipinos, surviving illness means not just enduring pain, but navigating a bureaucratic maze to beg for help. Families desperate for life-saving treatment are often forced to chase government medical assistance from agency to agency, all while battling the crushing emotional and financial toll of disease.

Those confined in public hospitals may have better chances at receiving subsidies. But for middle-income patients and outpatients—those who don’t qualify as indigent yet are still financially vulnerable—the struggle is often harder.

Many end up resorting to repeated applications for aid from the Department of Health (DOH), Department of Social Welfare and Development (DSWD) and the Philippine Charity Sweepstakes Office (PCSO). Still, assistance remains uncertain.

When all else fails, patients turn to politicians for “guarantee letters,” informal pledges to cover treatment costs. This is not just a workaround. It reflects a healthcare system that relies too heavily on political favor, rather than rights-based access. It undermines dignity, fairness and trust in public institutions.

To be fair, the government and private partners have expanded access through subsidy programs and collaborative initiatives. These efforts matter. However, these remain fragmented and incomplete. At the heart of the challenge is a systemic choke point: the Health Technology Assessment (HTA), mandated under the Universal Health Care (UHC) Act of 2019.

HTA is designed to ensure government funds go toward safe, effective, and cost-efficient health technologies—a necessary safeguard. But when this assessment process is slow and rigid, it prevents new treatments from reaching those who need them most.

Innovative therapies, especially for rare diseases and complex conditions like cancer, often remain excluded from government procurement and reimbursement systems simply because they lack a positive HTA recommendation.

This slow and rigid process is more than just red tape. It's a matter of life and death.

At the recent European Chamber of Commerce of the Philippines (ECCP) Healthcare Forum, experts from public and private sectors discussed access and innovation in the country’s healthcare landscape.

Dr. Jacinto Blas Mantaring III, chair of the Health Technology Assessment Council (HTAC), emphasized that HTA is not just about approval but prioritization—directing limited funds where they yield the most value. This is sound in principle. In practice, however, the process must evolve to keep pace with medical advancement and the urgency of patient needs.

Dr. Mantaring also acknowledged that current limitations in institutional capacity and budget create bottlenecks in the assessment pipeline.

This admission should galvanize stakeholders to advocate not just for faster timelines, but for increased investment in the HTA infrastructure itself. Without adequate resources, even the best frameworks will fail to deliver timely outcomes.

Delays in HTA evaluations have real-world consequences. Treatments already approved by the Food and Drug Administration (FDA) are often stuck in limbo, inaccessible to patients despite their proven benefits. Those living with fast-progressing illnesses can’t afford to wait years for a positive HTA recommendation. The cost of inaction is counted in lives lost.

Dr. Diana Edralin, ECCP Vice President and General Manager of Roche (Philippines) Inc., captured the stakes clearly: “This forum is more than just a dialogue. It is a convergence of brilliant minds and missions… to strengthen the infrastructure of Philippine healthcare and to ensure that innovations in medicine, technology, and systems reach especially those who need them the most.”

This underscores a crucial point: real reform requires collective commitment. Stronger collaboration between agencies, faster processing timelines, and an expanded view of value—including social and economic impact—are all essential.

As the Office of Health Economics (OHE) notes, taking a broader societal perspective in HTA decision-making can accelerate access to innovation and better align with public health priorities.

More importantly, the current system overlooks an important dynamic of outpatient care—a blind spot that affects countless Filipinos who require long-term treatment outside hospital settings.

Many chronic or rare conditions, such as hemophilia, epilepsy, or autoimmune disorders, require consistent and expensive therapies that aren't readily accessible without HTA approval. Ignoring this gap leaves patients vulnerable and care inconsistent.

HTA reform must also prioritize transparency. Too often, decisions are made behind closed doors, with limited avenues for civil society, patient groups, or medical experts to weigh in.

The process must invite more participation, especially from those who understand firsthand the cost of waiting. Providing clearer criteria, timelines, and rationales for HTA outcomes will build public trust and help patients prepare for what to expect. Transparency can act as both a quality check and a moral compass.

Currently, patients are left to navigate an exhausting, repetitive cycle of paperwork, referrals, and political appeals. The system’s failures force people to fight for care instead of receiving it.

Why must ordinary Filipinos jump through endless hoops to access medicines funded by their own taxes? Public assistance should be efficient, proactive, and centered on people’s needs. A more responsive HTA system would help achieve that.

We all support the vision of universal health care. But unless we reform how critical decisions are made and implemented, that vision risks becoming hollow. It’s not enough to pass good laws. We must execute them with speed, empathy, and accountability.

Access to innovative health technologies should never depend on who you know or how well you navigate bureaucracy. It should depend on what works, what’s needed, and what’s fair.

With President Ferdinand Marcos Jr.'s 4th State of the Nation Address (SONA), Filipinos await concrete action to fix the cracks in our healthcare system.

This is the time to end delays, dismantle red tape, and deliver real access to universal healthcare.

It’s time for government to move beyond its gatekeeping role and become a true enabler of health for all. This means embracing reforms that make HTA faster, more transparent, and more inclusive. Filipino lives depend on it. 

 

Alvin Manalansan is a health and nutrition fellow at the think tank Stratbase Institute and co-convenor of UHCWatch.

DEPARTMENT OF HEALTH

DEPARTMENT OF SOCIAL WELFARE AND DEVELOPMENT

PHILIPPINE CHARITY SWEEPSTAKES OFFICE

  • Latest
Latest
Latest
abtest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with